Arvin AM - Search Results

1

The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.

Bergen RE, Diaz PS, Arvin AM. Bergen RE, et al. Among authors: arvin am. J Infect Dis. 1990 Nov;162(5):1049-54. doi: 10.1093/infdis/162.5.1049. J Infect Dis. 1990. PMID: 2172393 Clinical Trial.

2

Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma.

Arvin AM, Pollard RB, Rasmussen LE, Merigan TC. Arvin AM, et al. J Infect Dis. 1978 May;137(5):531-40. doi: 10.1093/infdis/137.5.531. J Infect Dis. 1978. PMID: 207782

3

Cell-mediated immunity of cytomegalovirus infection in normal subjects and cardiac transplant patients.

Pollard RB, Rand KH, Arvin AM, Merigan TC. Pollard RB, et al. Among authors: arvin am. J Infect Dis. 1978 May;137(5):541-9. doi: 10.1093/infdis/137.5.541. J Infect Dis. 1978. PMID: 207783

4

Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.

Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM. Wilson A, et al. Among authors: arvin am. J Infect Dis. 1992 Jan;165(1):119-26. doi: 10.1093/infdis/165.1.119. J Infect Dis. 1992. PMID: 1309369

5

Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine.

Sharp M, Terada K, Wilson A, Nader S, Kinchington PE, Ruyechan WT, Hay J, Arvin AM. Sharp M, et al. Among authors: arvin am. J Infect Dis. 1992 May;165(5):852-8. doi: 10.1093/infdis/165.5.852. J Infect Dis. 1992. PMID: 1314871 Clinical Trial.

6

Cell-mediated immunity to varicella-zoster virus.

Arvin AM. Arvin AM. J Infect Dis. 1992 Aug;166 Suppl 1:S35-41. doi: 10.1093/infdis/166.supplement_1.s35. J Infect Dis. 1992. PMID: 1320649 Review.

7

Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.

Lowry PW, Solem S, Watson BN, Koropchak CM, Thackray HM, Kinchington PR, Ruyechan WT, Ling P, Hay J, Arvin AM. Lowry PW, et al. Among authors: arvin am. J Gen Virol. 1992 Apr;73 ( Pt 4):811-9. doi: 10.1099/0022-1317-73-4-811. J Gen Virol. 1992. PMID: 1321876

8

Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection.

Arvin AM. Arvin AM. Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S953-6. doi: 10.1093/clind/13.supplement_11.s953. Rev Infect Dis. 1991. PMID: 1664133 Review.

9

Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.

Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J. Arvin AM, et al. J Immunol. 1991 Jan 1;146(1):257-64. J Immunol. 1991. PMID: 1670603

10

Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.

Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM. Bergen RE, et al. Among authors: arvin am. Viral Immunol. 1991 Fall;4(3):151-66. doi: 10.1089/vim.1991.4.151. Viral Immunol. 1991. PMID: 1725699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters